Picture of Ascelia Pharma AB logo

ACE Ascelia Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Ascelia To Re-Evaluate Images With Independent Readers In Sparkle Study

Aug 18 (Reuters) - Ascelia Pharma AB  ACELP.ST :
    * WE WILL HAVE TO CONDUCT  NEW EVALUATION OF IMAGES WITH
INDEPENDENT READERS BEFORE WE CAN GENERATE RESULTS FROM SPARKLE
STUDY
    * ALTHOUGH RE-EVALUATION DOES NOT REQUIRE NEW OR ADDITIONAL
PATIENT RECRUITMENT OR CLINICAL DATA, THIS IS A SETBACK FOR
TIMELINES
    * WE WILL COMMUNICATE TIMELINE AND FINANCIAL IMPLICATIONS
FOR THIS
MID-SEPTEMBER
    * OUR CONFIDENCE IN POTENTIAL FOR ORVIGLANCE IS UNCHANGED

Source text for Eikon:  ID:nMFN3gCBpP 
Further company coverage:  ACELP.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))

Recent news on Ascelia Pharma AB

See all news